Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

News feed

Polyplast reported for 2025 under IFRS

15:26 -

Rusagro expanded the land bank by 5.2 thousand hectares

11:42 RAGR

Fesco launches container service between Cambodia and Russia

11:16 FESH

Sollers launches production of passenger version of Sollers SF1

10:06 SVAV

Yandex registers trademarks for autonomous transportation

09:59 YDEX

Sales of Softline's own solutions in 2025 increased by 22%

09:34 SOFL

Softline reports for 2025 in accordance with IFRS

09:21 SOFL

State will not give money to the Samolet, but it can provide indirect assistance.

08:16 SMLT

Astra and PSB to create joint venture for industry solutions

08:03 ASTR

DOM.RF talked about plans for 2026

Yesterday at 17:24 DOMRF